Agilent Technologies, Inc. $A Shares Purchased by Sequoia Financial Advisors LLC

Sequoia Financial Advisors LLC raised its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 9.7% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 38,412 shares of the medical research company's stock after purchasing an additional 3,408 shares during the quarter. Sequoia Financial Advisors LLC's holdings in Agilent Technologies were worth $4,533,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in A. Generation Investment Management LLP grew its stake in shares of Agilent Technologies by 19.8% in the first quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company's stock valued at $582,976,000 after buying an additional 824,243 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Agilent Technologies by 18.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company's stock valued at $448,748,000 after acquiring an additional 604,124 shares during the period. Mackenzie Financial Corp lifted its position in shares of Agilent Technologies by 141.5% during the first quarter. Mackenzie Financial Corp now owns 935,893 shares of the medical research company's stock worth $109,481,000 after purchasing an additional 548,344 shares in the last quarter. Woodline Partners LP lifted its position in shares of Agilent Technologies by 681.6% during the first quarter. Woodline Partners LP now owns 522,073 shares of the medical research company's stock worth $61,072,000 after purchasing an additional 455,276 shares in the last quarter. Finally, Parnassus Investments LLC lifted its position in shares of Agilent Technologies by 38.3% during the first quarter. Parnassus Investments LLC now owns 1,577,999 shares of the medical research company's stock worth $184,594,000 after purchasing an additional 437,242 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on A. Rothschild Redb raised shares of Agilent Technologies to a "strong-buy" rating in a research note on Wednesday, October 8th. UBS Group upgraded Agilent Technologies from a "neutral" rating to a "buy" rating and lifted their target price for the company from $130.00 to $170.00 in a report on Wednesday, October 8th. Wall Street Zen upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a report on Friday, October 3rd. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Agilent Technologies in a research report on Wednesday, October 8th. Finally, Wells Fargo & Company increased their price target on Agilent Technologies from $140.00 to $150.00 and gave the company an "overweight" rating in a research report on Monday, September 15th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $149.62.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $138.12 on Wednesday. The company's fifty day moving average price is $125.97 and its 200 day moving average price is $117.31. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The firm has a market capitalization of $39.16 billion, a P/E ratio of 32.42, a P/E/G ratio of 4.51 and a beta of 1.26.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.37. The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business's quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter last year, the company posted $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be paid a $0.248 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies's payout ratio is currently 23.24%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.